Register Login

ZENTALIS PHARMACEUTICALS, INC. (ZNTL)

(19% Negative) ZENTALIS PHARMACEUTICALS, INC. (ZNTL) Announces Delay in approach Trials for Cancer Research (AACR) Annual Meeting Due to Regulatory Process, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot April 17, 2026, 7:11 p.m.

    📋 ZENTALIS PHARMACEUTICALS, INC. (ZNTL) - Clinical Trial Update

    Filing Date: 2026-04-17

    Accepted: 2026-04-17 15:11:03

    Event Type: Clinical Trial Update

    Event Details:

    ZENTALIS PHARMACEUTICALS, INC. (ZNTL) Announces Clinical Trial Update ZENTALIS PHARMACEUTICALS, INC. (ZNTL) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: approach, need
    • Diseases/Conditions: Cancer Research (AACR) Annual Meeting, ADC-resistant TNBC
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Regulatory Process
    • Collaboration: Cyclin E1

    🔬 Clinical Development Pipeline (ZENTALIS PHARMACEUTICALS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Azenosertib DRUG Phase PHASE1 Ovarian Cancer ClinicalTrials.gov
    Paclitaxel DRUG Phase PHASE1 Solid Tumor ClinicalTrials.gov
    Zentalis DRUG Phase PHASE2 Advanced Pancreatic Adenocarcinoma ClinicalTrials.gov
    Niraparib DRUG Phase PHASE1 Ovarian Cancer ClinicalTrials.gov
    ZN-c3 DRUG Phase PHASE1 Acute Myeloid Leukemia (AML) ClinicalTrials.gov
    ZN-d5 ZN-c3 DRUG Phase PHASE1 Acute Myeloid Leukemia (AML) ClinicalTrials.gov
    ZN-d5 DRUG Phase PHASE1 Amyloidosis ClinicalTrials.gov
    Cetuximab DRUG Phase PHASE1 Metastatic Colorectal Cancer ClinicalTrials.gov
    Encorafenib DRUG Phase PHASE1 Metastatic Colorectal Cancer ClinicalTrials.gov
    Gemzar DRUG Phase PHASE2 Advanced Pancreatic Adenocarcinoma ClinicalTrials.gov
    Gemcitabine DRUG Phase PHASE1 Osteosarcoma ClinicalTrials.gov
    Bevacizumab BIOLOGICAL Phase PHASE1 Solid Tumor ClinicalTrials.gov
    Pegylated liposomal doxorubicin DRUG Phase PHASE1 Solid Tumor ClinicalTrials.gov
    Carboplatin DRUG Phase PHASE1 Solid Tumor ClinicalTrials.gov
    Pembrolizumab DRUG Phase PHASE1 Tumors ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ZENTALIS PHARMACEUTICALS, INC.
    • Ticker Symbol: ZNTL

Search

News categories